Hematology, Transfusion and Cell Therapy
ISSN: 2531-1379
Hematology, Transfusion and Cell Therapy é uma publicação científica trimestral da Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Sociedade Brasileira de Transplante de Medula Óssea (SBTMO), Associazione Italo-Brasiliana di Ematologia (AIBE) e Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).
A Hematology, Transfusion and Cell Therapy publica artigos originais, artigos de revisão e relatos de caso relacionados com várias temáticas da área de hematologia e hemoterapia. Até 2017, a revista foi publicada sob o título Revista Brasileira de Hematologia e Hemoterapia.
ISSN print: 2531-1379
ISSN online: 2531-1387
Publicado por Elsevier Editora Ltda, Rio de Janeiro, Brasil.
Indexada em:
LILACS, SciELO Brazil, Scopus, and PubMed/PMC
Ver maisSiga-nos no:
CiteScore 2018
O CiteScore mede as citações médias recebidas por documento publicado. Mais informação
CiteScore 2018
0,74
SJR é uma métrica de prestígio baseada na idéia de que todas as citações não são iguais. SJR utiliza um algoritmo similar ao page rank do Google; é uma medida quantitativa e qualitativa ao impacto de uma publicação.
SJR
0,335
SNIP permite comparar o impacto de revistas de diferentes campos temáticos, corrigindo as diferenças na probabilidade de ser citado que existe entre revistas de distintas matérias.
SNIP
0,566
Ocultar
Número
Vol. 42. Núm. 1.Páginas 1-102 (January - March 2020)
Scientific comments
Comment on: Bacteremia in pediatric patients with hematopoietic stem transplantation
Antonio Vaz de Macedo
hematol Transfus Cell Ther. 2020;42:1-4
Open access
Original articles
Bacteremia in pediatric patients with hematopoietic stem cell transplantation
Paola Perez, Jaime Patiño, Mayra Estacio, Jessica Pino, Eliana Manzi, Diego Medina
hematol Transfus Cell Ther. 2020;42:5-11
Open access
Chronic transfusion therapy effectiveness as primary stroke prophylaxis in sickle cell disease patients
Juliana Moreira Franco, Carla Caroline Lopes Borges, Marília Alves Ansaloni, Renata Dudnick de Lima Mauro, Ylle Carolinne da Cruz Souza, Josefina Aparecida Pellegrini Braga
hematol Transfus Cell Ther. 2020;42:12-7
Open access
Cytomegalovirus disease in patients with hematopoietic stem cell transplantation, experience over 8 years
Laura Diaz, Joaquin Rosales, Fernando Rosso, Maria Rosales, Mayra Estacio, Eliana Manzi, Francisco Javier Jaramillo
hematol Transfus Cell Ther. 2020;42:18-24
Open access
Blood components requests at an orthopedic hospital: a critical survey
Aline Cury Borchardt, Fernanda Azevedo-Silva, Luiz de Melo Amorim Filho
hematol Transfus Cell Ther. 2020;42:25-32
Open access
Predictors of mortality among patients with acute leukemias admitted to an intensive care unit specialized in patients with hematological disease at a Brazilian hospital
Lorena Costa Corrêa, Dahra Teles, Odin Barbosa da Silva, Gustavo Henriques Trindade-Filho, Paula Loureiro, Maria do Socorro Mendonça Cavalcati
hematol Transfus Cell Ther. 2020;42:33-9
Open access
Haploidentical transplantation outcomes are comparable with those obtained with identical human leukocyte antigen allogeneic transplantation in Chilean patients with benign and malignant hemopathies
Mauricio Sarmiento, Pablo Ramirez, Veronica Jara, Pablo Bertin, Mauricio Galleguillos, Isabel Rodriguez, Carla Lorca, Isabel Pizarro, Elizabeth Rivera, Mauricio Ocqueteau
hematol Transfus Cell Ther. 2020;42:40-5
Open access
A subgroup analysis of JUMP, a phase IIIb, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis in a Brazilian cohort
Renato Tavares, Carmino Antonio De Souza, Carole Paley, Catherine Bouard, Ranjan Tiwari, Ricardo Pasquini
hematol Transfus Cell Ther. 2020;42:46-53
Open access
PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
Camile Valle Medawar, Gabriela Bittencourt Gonzalez Mosegui, Cid Manso de Mello Vianna, Talita Martins Alves da Costa
hematol Transfus Cell Ther. 2020;42:54-61
Open access
Review article
Venous thromboembolism in childhood: where is Brazil after 20 years?
Tayana Teixeira Mello, Jorge David Aivazoglou Carneiro, Guilherme Arantes Mello, Joyce Maria Annichinno Bizzacchi
hematol Transfus Cell Ther. 2020;42:62-9
Open access
Special article
A functional interaction between the CCR5 and CD34 molecules expressed in hematopoietic cells can support (or even promote) the development of cancer
Bruna Kulmann-Leal, Joel Henrique Ellwanger, José Artur Bogo Chies
hematol Transfus Cell Ther. 2020;42:70-6
Open access
Case reports
A case of multiple myeloma and synchronous liposarcoma
Ligia Cordeiro Matos Faial, Rose Mary Costa Rosa Andrade Silva, Eliane Ramos Pereira, Cidllan Silveira Gomes Faial
hematol Transfus Cell Ther. 2020;42:77-9
Open access
A case of neurocognitive deficit strongly related to dasatinib therapy
Kamal Chamoun, Emma Rabinovich, Linda Baer, Philip Fastenau, Marcos de Lima
hematol Transfus Cell Ther. 2020;42:80-2
Open access
Spontaneous splenic rupture associated with multiple myeloma: a serious and unusual case
Denise Fabri Rezende Engracia Mello, Mauro José Brandão da Costa, Eduardo Miguel Febronio, Glaucia Aparecida Magnani Landell, Rodolfo Mendes Queiroz
hematol Transfus Cell Ther. 2020;42:83-6
Open access
Coinheritance of beta-thalassemia minor and hereditary pyropoikilocytosis: case report
Flávio Augusto Naoum, Paulo Cesar Naoum
hematol Transfus Cell Ther. 2020;42:87-9
Open access
Letters to the editor
Interim interleukin 6 levels correlate with progression-free survival in patients with classic Hodgkin's disease: a pilot study
Pamela Villanova, Vitor Augusto Queiroz Mauad, Davimar Miranda Maciel Borducchi, Auro del Giglio
hematol Transfus Cell Ther. 2020;42:90-2
Open access
Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data
Sergio Augusto Buzian Brasil, Carolina Colaço, Tomas Barrese, Roberto P. Paes, Cristina Bortolheiro, Rodolfo Delfini Cançado
hematol Transfus Cell Ther. 2020;42:93-7
Open access
Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
Sakiyeva Kanshaiym, Gulmira Zhurabekova, Ibrahim A. Abdelazim, Tatyana Starchenko
hematol Transfus Cell Ther. 2020;42:98-9
Open access
Intravenous ferric carboxymaltose for the treatment of iron deficiency anaemia – reply
Rodolfo Delfini Cancado, João Ricardo Friedrisch
hematol Transfus Cell Ther. 2020;42:100-1
Open access
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.
Idiomas
Hematology, Transfusion and Cell Therapy